Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZYG11A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | ZSCAN26 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | ZRSR1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | ZNHIT6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | ZNF804A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF781 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | ZNF703 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ZNF697 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |